Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)

Clinical trial NCT00688948 · TERMINATED

Trial details

NCT number: NCT00688948
Sponsor: Nova Scotia Health Authority
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis Bladder Dysfunction

Start date: 2007-11-01
Primary completion: 2009-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.